DBVT

#2262
DBV Technologies S.A.
22.24 USD
+0.45%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
22.20
22.47
Faixa anual
7.00
26.19
Mudança diária
+0.45%
Mudança mensal
+8.54%
Mudança em 6 meses
+44.13%
Mudança anual
+200.95%
Fechamento anterior
22.14
Abrir
22.40
Bid
Ask
Mínimo
22.20
High
22.47
Volume
37
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.32 B
  • Employee 125
  • Founded 2002
  • CEO N/A
  • Website www.dbv-technologies.com
  • Headquarter France
  • FIGI BBG0076D3T39
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-18.26
Price to sales ratio
474.74

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Notícias